An in-vitro study conducted on a human ovarian cancer cell line (SKOV3) demonstrated the role of MDM2 in promoting EMT through inhibition of E-cadherin and activation of various growth-promoting transcription factors e.g., TGF-β/Smads and Snail/Slug [48, 87]. Here, MDM2 is linked to ovarian carcinoma.